AEF0217

DRUG2 trials

Sponsors

Aelis Farma

Conditions

Down SyndromeSafety, Tolerability, Pharmacokinetics of AEF0217

Phase 1

AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.

CompletedNCT05170737

Aelis FarmaSafety, Tolerability, Pharmacokinetics of AEF0217

Start: 2021-10-01End: 2022-06-28Updated: 2024-02-01

Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome

CompletedNCT05748405

Aelis FarmaDown Syndrome

Start: 2022-12-15End: 2024-10-07Updated: 2024-10-10